NCT00002677View on ClinicalTrials.gov

Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 1995

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions
Prostate CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

chemotherapy

DRUG

tributyrin

Trial Locations (1)

21201

Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Maryland, Baltimore

OTHER

NCT00002677 - Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors | Biotech Hunter | Biotech Hunter